Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
252
-
Total 13F shares, excl. options
-
169M
-
Shares change
-
-575K
-
Total reported value, excl. options
-
$7.66B
-
Value change
-
+$1.88M
-
Put/Call ratio
-
2.38
-
Number of buys
-
140
-
Number of sells
-
-84
-
Price
-
$45.35
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q3 2024
284 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q3 2024.
Revolution Medicines, Inc. - Common Stock (RVMD) has 252 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 169M shares
of 186M outstanding shares and own 90.69% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14.9M shares), BlackRock, Inc. (13.9M shares), WELLINGTON MANAGEMENT GROUP LLP (11.4M shares), FARALLON CAPITAL MANAGEMENT LLC (11.3M shares), BAKER BROS. ADVISORS LP (7.57M shares), Nextech Invest Ltd. (6.3M shares), JANUS HENDERSON GROUP PLC (6.14M shares), FMR LLC (5.88M shares), Paradigm Biocapital Advisors LP (5.31M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (5.31M shares).
This table shows the top 252 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.